ESRRA and metabolic dysfunction-associated steatotic liver disease: Estrogen-related receptor alpha (ERRα) was reported to contribute to the sex disparity in NAFLD development by regulating hepatic triglyceride biosynthesis and VLDL assembly and secretion, providing a novel treatment target [42,43].